PT1229906E - Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos - Google Patents

Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos Download PDF

Info

Publication number
PT1229906E
PT1229906E PT00957914T PT00957914T PT1229906E PT 1229906 E PT1229906 E PT 1229906E PT 00957914 T PT00957914 T PT 00957914T PT 00957914 T PT00957914 T PT 00957914T PT 1229906 E PT1229906 E PT 1229906E
Authority
PT
Portugal
Prior art keywords
mesoprogestins
prevention
treatment
hormone dependent
gynecological disorders
Prior art date
Application number
PT00957914T
Other languages
English (en)
Portuguese (pt)
Inventor
Kristof Chwalisz
Walter Elger
Gerd Schubert
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PT1229906E publication Critical patent/PT1229906E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
PT00957914T 1999-08-31 2000-08-31 Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos PT1229906E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38614199A 1999-08-31 1999-08-31

Publications (1)

Publication Number Publication Date
PT1229906E true PT1229906E (pt) 2008-01-18

Family

ID=23524338

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00957914T PT1229906E (pt) 1999-08-31 2000-08-31 Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos

Country Status (34)

Country Link
EP (1) EP1229906B1 (https=)
JP (1) JP2003535029A (https=)
KR (3) KR20080066095A (https=)
AR (1) AR025457A1 (https=)
AT (1) ATE375160T1 (https=)
AU (1) AU781840B2 (https=)
BG (1) BG65817B1 (https=)
BR (1) BR0014161A (https=)
CA (1) CA2382580C (https=)
CO (1) CO5200772A1 (https=)
CZ (1) CZ2002704A3 (https=)
DE (1) DE60036723T2 (https=)
DK (1) DK1229906T3 (https=)
EA (1) EA007854B1 (https=)
EE (1) EE05172B1 (https=)
ES (1) ES2295050T3 (https=)
HR (1) HRP20020267A2 (https=)
HU (1) HUP0202429A3 (https=)
IL (1) IL148416A0 (https=)
LT (1) LT5034B (https=)
LV (1) LV12941B (https=)
ME (1) MEP13808A (https=)
MX (1) MXPA02002191A (https=)
NO (1) NO20020999L (https=)
NZ (1) NZ517471A (https=)
PE (1) PE20010578A1 (https=)
PL (1) PL198790B1 (https=)
PT (1) PT1229906E (https=)
RO (1) RO122179B1 (https=)
RS (1) RS50283B (https=)
SI (1) SI20852B (https=)
SK (1) SK287192B6 (https=)
UA (1) UA78184C2 (https=)
WO (1) WO2001015679A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003255355A1 (en) * 2002-08-02 2004-02-25 Schering Aktiengesellschaft Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
US20040097591A1 (en) * 2002-11-18 2004-05-20 Kristof Chwalisz Use of selective progesterone receptor modulators for the treatment of androgen deficiency
RU2301691C1 (ru) * 2005-12-20 2007-06-27 Государственное учреждение Научный центр акушерства, гинекологии и перинатологии Российской академии медицинских наук Способ восстановительного лечения женщин репродуктивного возраста с тазовыми перитонеальными спайками с фиксированной или субфиксированной ретродевиацией матки
DE102007011105A1 (de) 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
RU2339392C1 (ru) * 2007-05-21 2008-11-27 Федеральное Государственное учреждение Научный центр акушерства, гинекологии и перинатологии Росмедтехнологий Способ остановки маточных кровотечений в пубертатном периоде
JP4709328B2 (ja) * 2009-06-17 2011-06-22 国立大学法人 熊本大学 月経困難症の予防及び／又は治療薬
US8399432B2 (en) * 2009-10-27 2013-03-19 Lipogen Ltd. Compositions and methods of treatment for alleviating premenstrual syndrome symptoms
JP2022548314A (ja) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法
US12426782B2 (en) 2020-11-06 2025-09-30 The Board Of Trustees Of The Leland Stanford Junior University Systems and temporal alignment methods for evaluation of gestational age and time to delivery

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633244A1 (de) 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese
DE4332284C2 (de) 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
US5696127A (en) * 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
EP1043325B1 (en) * 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
UA37259C2 (uk) 1995-02-02 2001-05-15 Шерінг Актієнгезеллшафт Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
WO1997041145A1 (en) * 1996-05-01 1997-11-06 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
EP1144396A2 (en) * 1999-01-14 2001-10-17 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
HK1043788A1 (zh) * 1999-05-04 2002-09-27 American Home Products Corporation 四環黃體酮受體調節劑化合物及方法

Also Published As

Publication number Publication date
ATE375160T1 (de) 2007-10-15
PL353930A1 (en) 2003-12-15
CA2382580C (en) 2009-05-19
RS50283B (sr) 2009-09-08
KR20070058023A (ko) 2007-06-07
HUP0202429A3 (en) 2004-04-28
LT5034B (lt) 2003-07-25
WO2001015679A3 (en) 2001-11-22
EE05172B1 (et) 2009-06-15
UA78184C2 (en) 2007-03-15
MEP13808A (en) 2010-06-10
JP2003535029A (ja) 2003-11-25
SI20852A (sl) 2002-10-31
DE60036723D1 (de) 2007-11-22
EE200200104A (et) 2003-04-15
AU781840B2 (en) 2005-06-16
KR20020027616A (ko) 2002-04-13
ES2295050T3 (es) 2008-04-16
KR100864547B1 (ko) 2008-10-20
NZ517471A (en) 2004-02-27
DK1229906T3 (da) 2008-02-11
EA200200282A1 (ru) 2002-10-31
WO2001015679A2 (en) 2001-03-08
CZ2002704A3 (cs) 2003-02-12
AU6946600A (en) 2001-03-26
PE20010578A1 (es) 2001-06-04
CA2382580A1 (en) 2001-03-08
CO5200772A1 (es) 2002-09-27
NO20020999L (no) 2002-03-14
YU14002A (sh) 2006-01-16
DE60036723T2 (de) 2008-07-17
BG65817B1 (bg) 2010-01-29
SK287192B6 (sk) 2010-02-08
HUP0202429A2 (en) 2002-10-28
BR0014161A (pt) 2002-05-21
EA007854B1 (ru) 2007-02-27
KR100755109B1 (ko) 2007-09-04
EP1229906A2 (en) 2002-08-14
AR025457A1 (es) 2002-11-27
NO20020999D0 (no) 2002-02-28
BG106442A (bg) 2002-09-30
MXPA02002191A (es) 2002-09-30
EP1229906B1 (en) 2007-10-10
RO122179B1 (ro) 2009-02-27
PL198790B1 (pl) 2008-07-31
SK2992002A3 (en) 2002-07-02
LT2002031A (en) 2003-02-25
SI20852B (sl) 2009-06-30
IL148416A0 (en) 2002-09-12
HRP20020267A2 (en) 2004-04-30
LV12941B (en) 2003-06-20
KR20080066095A (ko) 2008-07-15

Similar Documents

Publication Publication Date Title
IL127664A (en) Compositions for the treatment and prevention of cachexia
HUP0104676A3 (en) Compositions for the treatment of anorectal disorders and their use
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
PT1229906E (pt) Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos
GB9808936D0 (en) Combination therapy for the prevention and treatment of osteoporosis
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU7601400A (en) Treatment and prevention of hepatic disorders
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
IL148640A0 (en) Processes for the preparation of sumatriptan and related compounds
PL349910A1 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
AU1028501A (en) Isoquinoline and quinazoline derivatives for the treatment of cns disorders
PL347976A1 (en) Isonipecotamides for the treatment of integrin−mediated disorders
AU2566201A (en) Compounds and methods for the treatment of pain
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
GB9904252D0 (en) Composition for the treatment of pain
IL150202A0 (en) Method and composition for the treatment of pain
IL143903A0 (en) Use of phanquinone for the treatment or prevention of memory impairment
AU2420201A (en) Compounds and methods for the treatment of pain
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases